Nanoscope in the News

14 Emerging Tech Trends for 2021—and Dallas-Area Companies That Are Innovating for the Future
March 6, 2021 by Nanoscope Therapeutics
Nature: Light-activated genetic therapy to treat blindness enters clinic
February 9, 2021 by Nanoscope Therapeutics
Injection that could improve fading sight in aging eyes starts human trials after curing blindness in mice
October 22, 2020 by Nanoscope Therapeutics
Human trials for genetic jab that lets blind mice see again
October 22, 2020 by Nanoscope Therapeutics
Nanoscope Therapeutics Closes Series A, Names Alvaro Guillem as Chairman
July 21, 2020 by Nanoscope Therapeutics
Two TechFW Clients Receive Awards from NASA and the National Eye Institute
June 1, 2020 by Nanoscope Therapeutics
Dallas Morning News: Bedford biomedical firm wins major backing for tech that could restore damaged retinas
September 24, 2018 by Nanoscope Therapeutics

Samarendra Mohanty (Co-Founder/President) has decades of Biomedical Technologies experience in Asia, Europe and USA. He has authored over 200 publications and patents. He is the Primary Investigator for major grants from National Eye Institute including Audacious Goal Initiative and Bioengineering Research grants. He serves on the editorial board of journals and chairs international conference on optogenetics. He is winner of 2019 Healthcare Heroes award.

Nanoscope in the News

Nanoscope in the News

Dr. Samarendra Mohanty, PhD | Co-Founder & President